Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer
Küçük Resim Yok
Tarih
2016
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
American Society of Clinical Oncology
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
[Abstract Not Available]
Açıklama
Anahtar Kelimeler
Thrombin, Prothrombin, Colorectal Cancer
Kaynak
Gastrointestinal Cancers Symposium
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
34
Sayı
4
Künye
Salman, T., Bilici, A., Arslan, Ç., Varol, U., Yıldız, İ., Akyol, M. ... Yılmaz, U. (2016). Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer. Gastrointestinal Cancers Symposium. San Francisco, California, January 21-23, 2016. https://dx.doi.org/10.1200/jco.2016.34.4_suppl.615
